|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.82 HKD | +2.69% |
|
-4.68% | -1.25% |
| Feb. 25 | Simcere Pharmaceutical Group Limited acquired Xianwei Biotechnology Co., Ltd. | CI |
| Feb. 25 | Simcere Pharmaceutical Forecasts Up to 94% Boost in 2025 Profit | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 2.44% | 3.04% | 20.08x | 3.21x | 3.35x | 16.08x | 19.56x | 3.81B | |
| 0.83% | 0.93% | 36.68x | 5.33x | 6.98x | 23.91x | 29.03x | 46.62B | |
| 1.4% | 1.5% | 18.53x | 1.65x | 1.96x | 9.53x | 12.68x | 34.02B | |
| 1.04% | 1.06% | 25.57x | 3.11x | 3.45x | 16.3x | 20.1x | 11.67B | |
| 0.89% | 0.87% | 20.25x | 3.3x | 3.51x | 13.08x | 15.78x | 10.02B | |
| 3.56% | 3.88% | 18.86x | 3.15x | 3.23x | 11.98x | 14.43x | 8.17B | |
| 1.12% | 1.23% | 79.93x | 6.19x | - | - | - | 7.78B | |
| 3.13% | 3.14% | 16.89x | 1.44x | 2.19x | 8.26x | 11.07x | 7.43B | |
| 0.14% | 0.16% | 33.28x | 5.75x | 3.6x | 16.39x | 17.18x | 6.48B | |
| 4.53% | 5.15% | 9.39x | 1.51x | 2.05x | 5.54x | 6.66x | 6.33B | |
| 0.21% | 0.21% | 40.41x | 5.46x | 4.41x | 19.96x | 27.83x | 4.43B | |
| 1.12% | 1.29% | 35.04x | 8.25x | 6.75x | 24.84x | 27.71x | 4.05B | |
| 1.69% | 1.93% | 12.31x | 0.7x | 2.08x | 8.67x | 10.52x | 3.8B | |
| 2.58% | 2.83% | 15.57x | 3.6x | 3.67x | 13.14x | 14.41x | 2.9B | |
| 3.1% | 3.29% | 19.37x | 5.32x | 6.18x | 17.63x | 18.75x | 2.5B | |
| Average | 1.85% | 2.03% | 26.81x | 3.87x | 3.81x | 14.67x | 17.55x | 10.67B | |
| Weighted average by Cap. | 1.47% | 1.6% | 28.48x | 3.76x | 4.20x | 15.94x | 19.51x |
Select your edition
All financial news and data tailored to specific country editions
